TCM Intrinsic Value
TCM (TCMLMTD) median intrinsic value is ₹31.25 from 2 valuation models (range ₹20–₹31), vs current price ₹43.40 — -28.0% downside (Trading Above Calculated Value), margin of safety -38.9%. Read TCM dividend policy for the complete payout history and dividend yield track record.
TCMLMTD Valuation Methods Summary — DCF, Graham Number & P/E
TCM intrinsic value across 2 models vs current price ₹43.40 — upside/downside and value range per method. For current market price and key ratios, visit TCMLMTD stock price BSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹31.25 | ₹28.12 - ₹34.38 | -28.0% | Book Value/Share: ₹31.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹20.00 | ₹18.00 - ₹22.00 | -53.9% | Revenue/Share: ₹25.00, P/S: 0.8x |
TCMLMTD Intrinsic Value vs Market Price — All Valuation Models
TCM fair value range ₹20–₹31 vs current market price ₹43.40 across 2 valuation models. Analyse TCMLMTD institutional holdings to track promoter, FII and institutional holdings.
TCMLMTD Intrinsic Value Analysis — Undervalued or Overvalued?
TCM median intrinsic value ₹31.25, current price ₹43.40 — Trading Above Calculated Value by 28.0%, margin of safety -38.9%.
What is the intrinsic value of TCMLMTD?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of TCM (TCMLMTD) is ₹31.25 (median value). With the current market price of ₹43.40, this represents a -28.0% variance from our estimated fair value.
The valuation range spans from ₹20.00 to ₹31.25, indicating ₹20.00 - ₹31.25.
Is TCMLMTD undervalued or overvalued?
Based on our multi-method analysis, TCM (TCMLMTD) appears to be trading above calculated value by approximately 28.0%.
TCMLMTD Financial Health — Key Ratios vs Industry Benchmarks
TCM financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -32.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -24.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.24x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
TCMLMTD Cash Flow Quality — Operating & Free Cash Flow
TCM operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |